Global molecular cytogenetics market is estimated to grow at a CAGR of 8.5% during the forecast period. Molecular cytogenetics is defined as a specific focus of biomedical sciences targeted at studying chromosomes at molecular resolutions and all stages of the cell cycle. It comprises a set of techniques that operate with either the entire genome or specific DNA sequences to analyze genomic structural and behavioral variations at the chromosomal or subchromosomal level. Genomic variations are an important factor for human biodiversity and disease and molecular cytogenetics has many applications in research, clinical diagnostics, and treatment of genetic disorders and cancer. The continuous rise in such cases has emphasized the need for the development of advanced technologies for a comprehensive understanding of cancer at a genomic level. According to World Organization (WHO) by 2040, the global burden is anticipated to grow to 27.5 million new Cancer cases due to the growth and aging of the population. Thus, the growth of the molecular cytogenetics market is attributed to the rising number of genetic disorders and cancer globally. Also, according to the world cancer research fund, there were an estimated 18.1 million cancer cases around the globe in 2020. Of these, 9.3 million cases were in men and 8.8 million in women.
Browse the full report description of “Molecular Cytogenetics Market Size, Share & Trends Analysis Report by Product (Consumables, Software & Services, and Instruments), by Application (Cancer, Genetic Disorders, and Personalized Medicine), and by Technique (Fluorescence in Situ Hybridization (FISH), Comparative Genomic Hybridization (CGH), and Others) Forecast Period (2023-2030)” at https://www.omrglobal.com/industry-reports/molecular-cytogenetics-market
Also, advancements in molecular cytogenetic techniques and technologies are driving the growth of the market. For instance, in March 2020, Agilent Technologies unveiled three new microarrays to support pre- and postnatal research by cytogenetic laboratories. The geniture cyto microarrays feature updated and clinically relevant content from respected databases, according to the firm. Additionally, the microarray probes yield high-resolution detection of copy number variations and copy-neutral loss of heterozygosis associated with developmental delays, neuropsychiatric disorders, intellectual disability, congenital anomalies, or unexplained dimorphic features in constitutional DNA samples.
Market Coverage
• The market number available for – 2022-2030
• Base year- 2022
• Forecast period- 2023-2030
• Segment Covered-
o By Product
o By Application
o By Technique
• Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
• Competitive Landscape- Abbott Laboratories, Inc., ADS Biotec Inc., Agilent Technologies, Inc., Applied Spectral Imaging, and others.
Key questions addressed by the report
• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?
Global Molecular Cytogenetic Market Report Segment
By Product
By Application
By Technique
Global Molecular Cytogenetic Market Report Segment by Region
North America
• United States
• Canada
Europe
• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe
Asia-Pacific
• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific
Rest of the World
• Latin America
• Middle East & Africa
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/molecular-cytogenetics-market